Revolution Medicines, Inc.
RVMDNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $39.43B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $52.48$224.31
- Volume (live)
- -
- Avg. volume (3M)
- 2.25M
Revolution Medicines (RVMD) Stock Price & Financial Analysis
Revolution Medicines Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $181.00 - $188.30 |
|---|---|
| 52-Week High | $224.31 |
| 52-Week Low | $52.48 |
| Open | $186.99 |
| Volume (last close) | 1.66M |
| Average Volume (3M) | 2.25M |
| 50-Day MA | $202.45 |
|---|---|
| 200-Day MA | $152.72 |
| 1-Year Change | +251.22% |
| Market Cap | 39.43B |
|---|---|
| Shares Outstanding | 210.89M |
| Price to Book (P/B) | 15.13 |
| EV/EBITDA | -22.84 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Revolution Medicines at a Glance
As of the Oct 26, 2026 close, Revolution Medicines (RVMD) has a market capitalization of $39.43B.
As of its latest reported balance sheet, it holds $815.43M in cash and securities against $504.19M of debt, a net cash position of $311.25M.
Revolution Medicines does not currently pay a dividend.
The share price is up 251.2% over the past year. At $183.90 (the Oct 26, 2026 close) it sits within its 52-week range of $52.48 to $224.31, above its 200-day moving average of $152.72.
Based on 26 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $257.41, 40.0% above the Oct 26, 2026 close.
Frequently Asked Questions About Revolution Medicines
What is the current stock price for RVMD?
As of the Oct 26, 2026 close, RVMD stock trades at $183.90. The 52-week range is $52.48–$224.31, with a day range of $181.00–$188.30.
What is the P/E ratio for RVMD?
The P/E ratio (Price-to-Earnings) for RVMD is shown in the Key Statistics section. This valuation metric helps compare Revolution Medicines, Inc. to industry peers.
Does RVMD pay dividends?
Revolution Medicines does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for RVMD?
Based on ratings from 26 professional analysts over the last 90 days, the consensus for RVMD is Buy. The average 12-month price target is $257.41, a 40.0% upside from the Oct 26, 2026 close of $183.90.
What is the market cap of RVMD?
As of the Oct 26, 2026 close, Revolution Medicines's market capitalization is $38.78B, classifying it as a large-cap company. Revolution Medicines operates in the Healthcare sector within the Biotechnology industry.